Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice

We examined whether two types of xylooligosaccharides (neutral or acidic xylooligosaccharides) derived from hardwood kraft pulp ameliorate the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of picryl chloride (PiCl) in NC/Nga mice. Oral administration of acid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Nutritional Science and Vitaminology 2010, Vol.56(1), pp.54-59
Hauptverfasser: Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan), Sakaino, M, Takahashi, T, Azumi, N, Ishikawa, K, Kawazoe, S, Kobayashi, Y, Kido, Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 59
container_issue 1
container_start_page 54
container_title Journal of Nutritional Science and Vitaminology
container_volume 56
creator Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan)
Sakaino, M
Takahashi, T
Azumi, N
Ishikawa, K
Kawazoe, S
Kobayashi, Y
Kido, Y
description We examined whether two types of xylooligosaccharides (neutral or acidic xylooligosaccharides) derived from hardwood kraft pulp ameliorate the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of picryl chloride (PiCl) in NC/Nga mice. Oral administration of acidic xylooligosaccharides at a daily dose of 100 mg/kg significantly prevented the development of AD-like skin lesions. Serum histamine level was significantly suppressed, but serum total IgE level was not significantly suppressed. Moreover, the secretion of inflammatory cytokine IL-12 from splenic lymphocytes was significantly suppressed. On the other hand, neutral xylooligosaccharides showed no significant preventive effect on the development of AD-like symptoms. These results suggest that oral administration of acidic xylooligosaccharides may be effective in preventing the development of AD-like skin disease and one of the mechanisms is the suppressive effect on IL-12.
doi_str_mv 10.3177/jnsv.56.54
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3177_jnsv_56_54</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20354347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-87a215e6123d25a5b4fdda7a0149a6cda7237c829667285c1a67aa8659460dc03</originalsourceid><addsrcrecordid>eNpFkEtvEzEUhS0Eomlgwx7kDZtKk_ptZ4VQxFNVywLWo1vbkzr1jEe2qeiSf45DQtjce2R_9xzpIPSKkhWnWl_upvKwkmolxRO0oMbQTmvBnqIF4YR2whByhs5L2REi1kaY5-iMES4FF3qBft9kiBjcGKZQaoYa0oTTgMEGFyz-9RhTimGbClh7Bzk4X_Cc_YOfasH1zmPXdEzz2B7-3tU0tzvn89i8aihdDPcel_sw4ehLcy-4yevN5fUW8Bisf4GeDRCLf3ncS_Tj44fvm8_d1c2nL5v3V52VmtbOaGBUekUZd0yCvBWDc6CBULEGZZtkXFvD1kppZqSloDSAUXItFHGW8CW6OPjanErJfujnHEbIjz0l_b7Hft9jL1XfqlmiNwd4_nk7endC_xXXgLdHAIqFOGSYbCj_Oaa5EGKf-u7A7UqFrT8BkGuw0Z8y6XGI08--7t5PzeH1wWGA1MM2t5Sv3xihhBDGGOd_AAxFna0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan) ; Sakaino, M ; Takahashi, T ; Azumi, N ; Ishikawa, K ; Kawazoe, S ; Kobayashi, Y ; Kido, Y</creator><creatorcontrib>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan) ; Sakaino, M ; Takahashi, T ; Azumi, N ; Ishikawa, K ; Kawazoe, S ; Kobayashi, Y ; Kido, Y</creatorcontrib><description>We examined whether two types of xylooligosaccharides (neutral or acidic xylooligosaccharides) derived from hardwood kraft pulp ameliorate the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of picryl chloride (PiCl) in NC/Nga mice. Oral administration of acidic xylooligosaccharides at a daily dose of 100 mg/kg significantly prevented the development of AD-like skin lesions. Serum histamine level was significantly suppressed, but serum total IgE level was not significantly suppressed. Moreover, the secretion of inflammatory cytokine IL-12 from splenic lymphocytes was significantly suppressed. On the other hand, neutral xylooligosaccharides showed no significant preventive effect on the development of AD-like symptoms. These results suggest that oral administration of acidic xylooligosaccharides may be effective in preventing the development of AD-like skin disease and one of the mechanisms is the suppressive effect on IL-12.</description><identifier>ISSN: 0301-4800</identifier><identifier>EISSN: 1881-7742</identifier><identifier>DOI: 10.3177/jnsv.56.54</identifier><identifier>PMID: 20354347</identifier><language>eng</language><publisher>Tokyo: Center for Academic Publications Japan</publisher><subject>acidic xylooligosaccharides ; Acids ; ADMINISTRACION ORAL ; ADMINISTRATION ORALE ; Administration, Oral ; Animals ; APPLICATION METHODS ; atopic dermatitis ; Biological and medical sciences ; CARBOHIDRATOS ; CARBOHYDRATES ; Cells, Cultured ; DERMATITE ; DERMATITIS ; Dermatitis, Atopic - immunology ; Dermatitis, Atopic - pathology ; Dermatitis, Atopic - prevention &amp; control ; ENFERMEDADES DE LA PIEL ; FACTEUR IMMUNOLOGIQUE ; FACTORES INMUNOLOGICOS ; Feeding. Feeding behavior ; Fundamental and applied biological sciences. Psychology ; GLUCIDE ; Histamine - blood ; http://www.fao.org/aos/agrovoc#c_10341 ; http://www.fao.org/aos/agrovoc#c_1300 ; http://www.fao.org/aos/agrovoc#c_27584 ; http://www.fao.org/aos/agrovoc#c_29621 ; http://www.fao.org/aos/agrovoc#c_34031 ; http://www.fao.org/aos/agrovoc#c_36803 ; http://www.fao.org/aos/agrovoc#c_4795 ; http://www.fao.org/aos/agrovoc#c_542 ; http://www.fao.org/aos/agrovoc#c_6259 ; http://www.fao.org/aos/agrovoc#c_7098 ; Immunoglobulin E - blood ; IMMUNOLOGICAL FACTORS ; interleukin-12 ; Interleukin-12 - metabolism ; INTERLEUKINE ; INTERLEUKINS ; INTERLEUQUINAS ; Lymphocytes - drug effects ; Magnoliopsida ; MALADIE DE LA PEAU ; Male ; METHODE D'APPLICATION ; METODOS DE APLICACION ; MICE ; Mice, Inbred Strains ; NC/Nga mouse ; OLIGOSACARIDOS ; OLIGOSACCHARIDE ; OLIGOSACCHARIDES ; Oligosaccharides - administration &amp; dosage ; Oligosaccharides - pharmacology ; Oligosaccharides - therapeutic use ; ORAL ADMINISTRATION ; Phytotherapy ; Plant Extracts - administration &amp; dosage ; Plant Extracts - pharmacology ; Plant Extracts - therapeutic use ; prebiotics ; PROTEINAS ; PROTEINE ; PROTEINS ; RATON ; Skin - drug effects ; Skin - immunology ; Skin - pathology ; SKIN DISEASES ; SOURIS ; Spleen - cytology ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Wood</subject><ispartof>Journal of Nutritional Science and Vitaminology, 2010, Vol.56(1), pp.54-59</ispartof><rights>2010 by the Center for Academic Publications Japan</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c571t-87a215e6123d25a5b4fdda7a0149a6cda7237c829667285c1a67aa8659460dc03</citedby><cites>FETCH-LOGICAL-c571t-87a215e6123d25a5b4fdda7a0149a6cda7237c829667285c1a67aa8659460dc03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22734440$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20354347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan)</creatorcontrib><creatorcontrib>Sakaino, M</creatorcontrib><creatorcontrib>Takahashi, T</creatorcontrib><creatorcontrib>Azumi, N</creatorcontrib><creatorcontrib>Ishikawa, K</creatorcontrib><creatorcontrib>Kawazoe, S</creatorcontrib><creatorcontrib>Kobayashi, Y</creatorcontrib><creatorcontrib>Kido, Y</creatorcontrib><title>Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice</title><title>Journal of Nutritional Science and Vitaminology</title><addtitle>J Nutr Sci Vitaminol</addtitle><description>We examined whether two types of xylooligosaccharides (neutral or acidic xylooligosaccharides) derived from hardwood kraft pulp ameliorate the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of picryl chloride (PiCl) in NC/Nga mice. Oral administration of acidic xylooligosaccharides at a daily dose of 100 mg/kg significantly prevented the development of AD-like skin lesions. Serum histamine level was significantly suppressed, but serum total IgE level was not significantly suppressed. Moreover, the secretion of inflammatory cytokine IL-12 from splenic lymphocytes was significantly suppressed. On the other hand, neutral xylooligosaccharides showed no significant preventive effect on the development of AD-like symptoms. These results suggest that oral administration of acidic xylooligosaccharides may be effective in preventing the development of AD-like skin disease and one of the mechanisms is the suppressive effect on IL-12.</description><subject>acidic xylooligosaccharides</subject><subject>Acids</subject><subject>ADMINISTRACION ORAL</subject><subject>ADMINISTRATION ORALE</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>APPLICATION METHODS</subject><subject>atopic dermatitis</subject><subject>Biological and medical sciences</subject><subject>CARBOHIDRATOS</subject><subject>CARBOHYDRATES</subject><subject>Cells, Cultured</subject><subject>DERMATITE</subject><subject>DERMATITIS</subject><subject>Dermatitis, Atopic - immunology</subject><subject>Dermatitis, Atopic - pathology</subject><subject>Dermatitis, Atopic - prevention &amp; control</subject><subject>ENFERMEDADES DE LA PIEL</subject><subject>FACTEUR IMMUNOLOGIQUE</subject><subject>FACTORES INMUNOLOGICOS</subject><subject>Feeding. Feeding behavior</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GLUCIDE</subject><subject>Histamine - blood</subject><subject>http://www.fao.org/aos/agrovoc#c_10341</subject><subject>http://www.fao.org/aos/agrovoc#c_1300</subject><subject>http://www.fao.org/aos/agrovoc#c_27584</subject><subject>http://www.fao.org/aos/agrovoc#c_29621</subject><subject>http://www.fao.org/aos/agrovoc#c_34031</subject><subject>http://www.fao.org/aos/agrovoc#c_36803</subject><subject>http://www.fao.org/aos/agrovoc#c_4795</subject><subject>http://www.fao.org/aos/agrovoc#c_542</subject><subject>http://www.fao.org/aos/agrovoc#c_6259</subject><subject>http://www.fao.org/aos/agrovoc#c_7098</subject><subject>Immunoglobulin E - blood</subject><subject>IMMUNOLOGICAL FACTORS</subject><subject>interleukin-12</subject><subject>Interleukin-12 - metabolism</subject><subject>INTERLEUKINE</subject><subject>INTERLEUKINS</subject><subject>INTERLEUQUINAS</subject><subject>Lymphocytes - drug effects</subject><subject>Magnoliopsida</subject><subject>MALADIE DE LA PEAU</subject><subject>Male</subject><subject>METHODE D'APPLICATION</subject><subject>METODOS DE APLICACION</subject><subject>MICE</subject><subject>Mice, Inbred Strains</subject><subject>NC/Nga mouse</subject><subject>OLIGOSACARIDOS</subject><subject>OLIGOSACCHARIDE</subject><subject>OLIGOSACCHARIDES</subject><subject>Oligosaccharides - administration &amp; dosage</subject><subject>Oligosaccharides - pharmacology</subject><subject>Oligosaccharides - therapeutic use</subject><subject>ORAL ADMINISTRATION</subject><subject>Phytotherapy</subject><subject>Plant Extracts - administration &amp; dosage</subject><subject>Plant Extracts - pharmacology</subject><subject>Plant Extracts - therapeutic use</subject><subject>prebiotics</subject><subject>PROTEINAS</subject><subject>PROTEINE</subject><subject>PROTEINS</subject><subject>RATON</subject><subject>Skin - drug effects</subject><subject>Skin - immunology</subject><subject>Skin - pathology</subject><subject>SKIN DISEASES</subject><subject>SOURIS</subject><subject>Spleen - cytology</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Wood</subject><issn>0301-4800</issn><issn>1881-7742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtvEzEUhS0Eomlgwx7kDZtKk_ptZ4VQxFNVywLWo1vbkzr1jEe2qeiSf45DQtjce2R_9xzpIPSKkhWnWl_upvKwkmolxRO0oMbQTmvBnqIF4YR2whByhs5L2REi1kaY5-iMES4FF3qBft9kiBjcGKZQaoYa0oTTgMEGFyz-9RhTimGbClh7Bzk4X_Cc_YOfasH1zmPXdEzz2B7-3tU0tzvn89i8aihdDPcel_sw4ehLcy-4yevN5fUW8Bisf4GeDRCLf3ncS_Tj44fvm8_d1c2nL5v3V52VmtbOaGBUekUZd0yCvBWDc6CBULEGZZtkXFvD1kppZqSloDSAUXItFHGW8CW6OPjanErJfujnHEbIjz0l_b7Hft9jL1XfqlmiNwd4_nk7endC_xXXgLdHAIqFOGSYbCj_Oaa5EGKf-u7A7UqFrT8BkGuw0Z8y6XGI08--7t5PzeH1wWGA1MM2t5Sv3xihhBDGGOd_AAxFna0</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan)</creator><creator>Sakaino, M</creator><creator>Takahashi, T</creator><creator>Azumi, N</creator><creator>Ishikawa, K</creator><creator>Kawazoe, S</creator><creator>Kobayashi, Y</creator><creator>Kido, Y</creator><general>Center for Academic Publications Japan</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2010</creationdate><title>Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice</title><author>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan) ; Sakaino, M ; Takahashi, T ; Azumi, N ; Ishikawa, K ; Kawazoe, S ; Kobayashi, Y ; Kido, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-87a215e6123d25a5b4fdda7a0149a6cda7237c829667285c1a67aa8659460dc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>acidic xylooligosaccharides</topic><topic>Acids</topic><topic>ADMINISTRACION ORAL</topic><topic>ADMINISTRATION ORALE</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>APPLICATION METHODS</topic><topic>atopic dermatitis</topic><topic>Biological and medical sciences</topic><topic>CARBOHIDRATOS</topic><topic>CARBOHYDRATES</topic><topic>Cells, Cultured</topic><topic>DERMATITE</topic><topic>DERMATITIS</topic><topic>Dermatitis, Atopic - immunology</topic><topic>Dermatitis, Atopic - pathology</topic><topic>Dermatitis, Atopic - prevention &amp; control</topic><topic>ENFERMEDADES DE LA PIEL</topic><topic>FACTEUR IMMUNOLOGIQUE</topic><topic>FACTORES INMUNOLOGICOS</topic><topic>Feeding. Feeding behavior</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GLUCIDE</topic><topic>Histamine - blood</topic><topic>http://www.fao.org/aos/agrovoc#c_10341</topic><topic>http://www.fao.org/aos/agrovoc#c_1300</topic><topic>http://www.fao.org/aos/agrovoc#c_27584</topic><topic>http://www.fao.org/aos/agrovoc#c_29621</topic><topic>http://www.fao.org/aos/agrovoc#c_34031</topic><topic>http://www.fao.org/aos/agrovoc#c_36803</topic><topic>http://www.fao.org/aos/agrovoc#c_4795</topic><topic>http://www.fao.org/aos/agrovoc#c_542</topic><topic>http://www.fao.org/aos/agrovoc#c_6259</topic><topic>http://www.fao.org/aos/agrovoc#c_7098</topic><topic>Immunoglobulin E - blood</topic><topic>IMMUNOLOGICAL FACTORS</topic><topic>interleukin-12</topic><topic>Interleukin-12 - metabolism</topic><topic>INTERLEUKINE</topic><topic>INTERLEUKINS</topic><topic>INTERLEUQUINAS</topic><topic>Lymphocytes - drug effects</topic><topic>Magnoliopsida</topic><topic>MALADIE DE LA PEAU</topic><topic>Male</topic><topic>METHODE D'APPLICATION</topic><topic>METODOS DE APLICACION</topic><topic>MICE</topic><topic>Mice, Inbred Strains</topic><topic>NC/Nga mouse</topic><topic>OLIGOSACARIDOS</topic><topic>OLIGOSACCHARIDE</topic><topic>OLIGOSACCHARIDES</topic><topic>Oligosaccharides - administration &amp; dosage</topic><topic>Oligosaccharides - pharmacology</topic><topic>Oligosaccharides - therapeutic use</topic><topic>ORAL ADMINISTRATION</topic><topic>Phytotherapy</topic><topic>Plant Extracts - administration &amp; dosage</topic><topic>Plant Extracts - pharmacology</topic><topic>Plant Extracts - therapeutic use</topic><topic>prebiotics</topic><topic>PROTEINAS</topic><topic>PROTEINE</topic><topic>PROTEINS</topic><topic>RATON</topic><topic>Skin - drug effects</topic><topic>Skin - immunology</topic><topic>Skin - pathology</topic><topic>SKIN DISEASES</topic><topic>SOURIS</topic><topic>Spleen - cytology</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Wood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan)</creatorcontrib><creatorcontrib>Sakaino, M</creatorcontrib><creatorcontrib>Takahashi, T</creatorcontrib><creatorcontrib>Azumi, N</creatorcontrib><creatorcontrib>Ishikawa, K</creatorcontrib><creatorcontrib>Kawazoe, S</creatorcontrib><creatorcontrib>Kobayashi, Y</creatorcontrib><creatorcontrib>Kido, Y</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of Nutritional Science and Vitaminology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohbuchi, T., Oji Paper Co. Ltd., Tokyo (Japan)</au><au>Sakaino, M</au><au>Takahashi, T</au><au>Azumi, N</au><au>Ishikawa, K</au><au>Kawazoe, S</au><au>Kobayashi, Y</au><au>Kido, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice</atitle><jtitle>Journal of Nutritional Science and Vitaminology</jtitle><addtitle>J Nutr Sci Vitaminol</addtitle><date>2010</date><risdate>2010</risdate><volume>56</volume><issue>1</issue><spage>54</spage><epage>59</epage><pages>54-59</pages><issn>0301-4800</issn><eissn>1881-7742</eissn><abstract>We examined whether two types of xylooligosaccharides (neutral or acidic xylooligosaccharides) derived from hardwood kraft pulp ameliorate the development of atopic dermatitis (AD)-like skin lesions induced by repeated application of picryl chloride (PiCl) in NC/Nga mice. Oral administration of acidic xylooligosaccharides at a daily dose of 100 mg/kg significantly prevented the development of AD-like skin lesions. Serum histamine level was significantly suppressed, but serum total IgE level was not significantly suppressed. Moreover, the secretion of inflammatory cytokine IL-12 from splenic lymphocytes was significantly suppressed. On the other hand, neutral xylooligosaccharides showed no significant preventive effect on the development of AD-like symptoms. These results suggest that oral administration of acidic xylooligosaccharides may be effective in preventing the development of AD-like skin disease and one of the mechanisms is the suppressive effect on IL-12.</abstract><cop>Tokyo</cop><pub>Center for Academic Publications Japan</pub><pmid>20354347</pmid><doi>10.3177/jnsv.56.54</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-4800
ispartof Journal of Nutritional Science and Vitaminology, 2010, Vol.56(1), pp.54-59
issn 0301-4800
1881-7742
language eng
recordid cdi_crossref_primary_10_3177_jnsv_56_54
source J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects acidic xylooligosaccharides
Acids
ADMINISTRACION ORAL
ADMINISTRATION ORALE
Administration, Oral
Animals
APPLICATION METHODS
atopic dermatitis
Biological and medical sciences
CARBOHIDRATOS
CARBOHYDRATES
Cells, Cultured
DERMATITE
DERMATITIS
Dermatitis, Atopic - immunology
Dermatitis, Atopic - pathology
Dermatitis, Atopic - prevention & control
ENFERMEDADES DE LA PIEL
FACTEUR IMMUNOLOGIQUE
FACTORES INMUNOLOGICOS
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
GLUCIDE
Histamine - blood
http://www.fao.org/aos/agrovoc#c_10341
http://www.fao.org/aos/agrovoc#c_1300
http://www.fao.org/aos/agrovoc#c_27584
http://www.fao.org/aos/agrovoc#c_29621
http://www.fao.org/aos/agrovoc#c_34031
http://www.fao.org/aos/agrovoc#c_36803
http://www.fao.org/aos/agrovoc#c_4795
http://www.fao.org/aos/agrovoc#c_542
http://www.fao.org/aos/agrovoc#c_6259
http://www.fao.org/aos/agrovoc#c_7098
Immunoglobulin E - blood
IMMUNOLOGICAL FACTORS
interleukin-12
Interleukin-12 - metabolism
INTERLEUKINE
INTERLEUKINS
INTERLEUQUINAS
Lymphocytes - drug effects
Magnoliopsida
MALADIE DE LA PEAU
Male
METHODE D'APPLICATION
METODOS DE APLICACION
MICE
Mice, Inbred Strains
NC/Nga mouse
OLIGOSACARIDOS
OLIGOSACCHARIDE
OLIGOSACCHARIDES
Oligosaccharides - administration & dosage
Oligosaccharides - pharmacology
Oligosaccharides - therapeutic use
ORAL ADMINISTRATION
Phytotherapy
Plant Extracts - administration & dosage
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
prebiotics
PROTEINAS
PROTEINE
PROTEINS
RATON
Skin - drug effects
Skin - immunology
Skin - pathology
SKIN DISEASES
SOURIS
Spleen - cytology
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Wood
title Oral administration of acidic xylooligosaccharides prevents the development of atopic dermatitis-like skin lesions in NC/Nga mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20administration%20of%20acidic%20xylooligosaccharides%20prevents%20the%20development%20of%20atopic%20dermatitis-like%20skin%20lesions%20in%20NC/Nga%20mice&rft.jtitle=Journal%20of%20Nutritional%20Science%20and%20Vitaminology&rft.au=Ohbuchi,%20T.,%20Oji%20Paper%20Co.%20Ltd.,%20Tokyo%20(Japan)&rft.date=2010&rft.volume=56&rft.issue=1&rft.spage=54&rft.epage=59&rft.pages=54-59&rft.issn=0301-4800&rft.eissn=1881-7742&rft_id=info:doi/10.3177/jnsv.56.54&rft_dat=%3Cpubmed_cross%3E20354347%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20354347&rfr_iscdi=true